BCA-225 Breast carcinoma associated glycoprotein 225, or BCA-225, has been identified exclusively in breast cancers and certain adenocarcinomas, as one of the biomarkers. Unlike other identified proteins, monoclonal antibodies for BCA-225 (clonesCU18, CU26, and CU46) show no cross reactivity with lactating mammary glands and with gastrointestinal malignancies. This restricted distribution and frequency in breast carcinomas gives BCA-225 considerable clinical significanc in diagnosis and treatment of breast and other adenocarcinomas.
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | Cu-18 |
| Source | Mouse |
| Tissue Type/Cancer Type | Breast Cancer |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
